Below we list the current VCT offers available for investment. Each is accompanied by a brief commentary. For each of our Featured Offers we also provide an extended research note.
VCTs are riskier than conventional investments so they're not for everyone. Before you invest you should ensure you have read and understood the product's Application Pack and the Risks and Commitments.
Pembroke is a fairly new entrant to the VCT market; however the manager, Oakley Capital, is a long established name in venture capital investing. This VCT is one of the few investing in growth-orientated companies: as such the recent rule changes on MBOs have little or no impact on them. Investments are focused on scalable consumer brands; ones which investors can walk down the high street and see. This VCT is worthy of consideration.
Albion is one of the longest established VCT managers. This offer allows investment into six of their existing VCTs. There is a broad spread of underlying investments in earlier stage technology, more mature asset backed businesses, renewable energy, healthcare and education. There is a strong credible team managing these.
Paul Jourdan, Amati's lead manager is a 16 year veteran of investing in smaller companies and launched his first VCT in 2005, which is now called Amati AIM VCT. Dr Jourdan has adapted his approach over the years and now focuses on companies that are cash-generative and growing. After two years the companies should also qualify for IHT exemption. This VCT is worthy of consideration.
The Calculus VCT looks for established businesses across a diverse range of sectors. It aims to provide an annual dividend of 4.5% of NAV from the first year of investment. Current holdings include Metropolitan Safe Deposits and Hampshire Cosmetics. Calculus was established in 1999 and has over £120m under management.
This new share class for the longstanding Downing Four VCT is looking to raise £10 million (with a further over-allotment of £10m) to invest in early-stage healthcare, biotechnology and life sciences businesses. Downing is the overall manager, but will use the skills of specialist healthcare investor BioScience Managers to source and manage deals.
This VCT will focus on overseas solar assets and investments into smart energy meters. An interesting addition to the VCT market coming from an experienced team, this will be one of the last to benefit from solar investments.
This generalist VCT has the enviable record of being the best performing VCT of all time in terms of investor total return, although of course past performance is not a guide to the future. There is a broad mix of investments within the portfolio including technology, greentech, software and many other sectors. Foresight is one of the leading private equity groups in the UK.
Giles Hargreave is one of the best known smaller company fund managers in the UK. His record speaks for itself, although clearly there is no guarantee he can repeat his performance. These VCTs are long standing and invest in a diverse range of businesses.
Maven is one of the premier VCT managers. Although this is the smallest VCT in its range, nonetheless it benefits from one of the strongest teams in the sector. Unlike many VCT managers, Maven has a wide UK coverage with 6 offices around the country. It has a particular specialism in energy. This VCT is worthy of consideration.
This is a top up offer to the long-standing Octopus AIM VCT and Octopus AIM VCT 2. Combined they have over £158 million of assets; each VCT has around 70 holdings. Investors can choose to allocate 100% to either VCT, or split them across both.
Investors will buy into a VCT with over £100 million of assets. Stability of capital is seen as more important than high growth. Investments in healthcare and renewable energy are key aspects of this portfolio.
Recent rule changes should have little impact on this VCT as it has always been focused on earlier stage growth-oriented companies. This huge VCT, at over £300 million in size, has around 60 companies across a wide range of sectors. The focus is on backing talented entrepreneurs. It has had some notable winners in the past including Zoopla, SwiftKey and Graze.
Unicorn is a specialist smaller company fund manager. This VCT has been a consistent long-term performer. The managers look for companies with strong cash flows and potential to pay and grow dividends over time. This is a large, well-diversified VCT and is worthy of consideration.
Downing FOUR VCT plc is creating two new share classes for subscription in the 2016/17 tax year – Generalist, and Healthcare.Downing FOUR was created in 2015 by merging four other VCTs that were managed or advised ...
This £70 million offer is a top up to the UK's largest VCT, Octopus Titan, which currently has assets of approximately £309 million. This long-standing VCT was first launched in 2007 and has around 60 companies ...
This is a top up to the longstanding Foresight VCT, raising £20 million with an over-allotment of £20 million. This is is a generalist evergreen VCT. Assuming full subscription this VCT will have assets of approximately ...
This is a top-up offer to the longstanding Octopus AIM VCT and Octopus AIM VCT 2. Combined they have over £158 million of assets; the first VCT has 71 holdings and the second has 69. Investors ...
This website is directed exclusively at, and intended to be used only by, persons in the UK who will be required to self-certify as Sophisticated Investors or High Net Worth Individuals before applying to invest in any of the products featured. It is not directed at any person where (by reason of nationality, residence, domicile or otherwise) the usage of the website is prohibited.
The investment products on this website are not for everyone. They are generally higher risk and require a longer investment term. You may get back less than you invest. It is therefore important that you understand the Risks and Commitments of these products.
We’ve made every effort to ensure the accuracy of the material on this website, but cannot guarantee its accuracy or currency. It reflects our understanding of current product and tax rules, which may change in future. It is for general information only and should not be regarded as constituting an offer or a solicitation to buy or sell any securities, or as investment or tax advice. If you are in any doubt as to the suitability of the products for your circumstances, please seek specialist financial or tax advice.
Wealth Club Limited is not responsible for the content of external third party material featured on our website.